The solute carrier family 10 (SLC10): beyond bile acid transport
about
Absorption-Enhancing Effects of Bile SaltsNTCP and beyond: opening the door to unveil hepatitis B virus entrySLC transporters as therapeutic targets: emerging opportunitiesStructural basis of the alternating-access mechanism in a bile acid transporterSolute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of HepatocytesCell Culture Models for the Investigation of Hepatitis B and D Virus InfectionRecent advances in understanding hepatic drug transportThe Concise Guide to PHARMACOLOGY 2013/14: transporters.Association of genetic variation of sodium taurocholate cotransporting polypeptide with chronic hepatitis B virus infection.Organic anion transporting polypeptide 1B3 can form homo- and hetero-oligomersStructural insights into the transport of small molecules across membranesSodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters.Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.Bile Acid Sodium Symporter BASS6 Can Transport Glycolate and Is Involved in Photorespiratory Metabolism in Arabidopsis thaliana.Intestinal transport and metabolism of bile acidsPlacental accommodations for transport and metabolism during intra-uterine crowding in pigsTranscriptomic Analysis of Trout Gill Ionocytes in Fresh Water and Sea Water Using Laser Capture Microdissection Combined with Microarray AnalysisNa+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats.Bile acid and sterol metabolism with combined HMG-CoA reductase and PCSK9 suppression.RNA-seq analyses of the midgut from blood- and serum-fed Ixodes ricinus ticks.c-Fos mediates repression of the apical sodium-dependent bile acid transporter by fibroblast growth factor-19 in miceFunctional transformations of bile acid transporters induced by high-affinity macromolecules.A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides.Glycosylation of solute carriers: mechanisms and functional consequences.Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma.Hepatitis B virus receptors and molecular drug targets.Oxidative Stress and Immune Responses During Hepatitis C Virus Infection in Tupaia belangeri.Mechanistic studies of the apical sodium-dependent bile acid transporter.Bile acids induce necrosis in pancreatic stellate cells dependent on calcium entry and sodium-driven bile uptake.Advancing hepatitis B virus entry inhibitorsHuman bile acid transporter ASBT (SLC10A2) forms functional non-covalent homodimers and higher order oligomers.From Classical Toxicology to Tox21: Some Critical Conceptual and Technological Advances in the Molecular Understanding of the Toxic Response Beginning From the Last Quarter of the 20th Century.CryoEM structure of the human SLC4A4 sodium-coupled acid-base transporter NBCe1.Characterization of a novel organic solute transporter homologue from Clonorchis sinensis.Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and NutrientsJaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases
P2860
Q26798510-6FE4C101-6F2C-42BC-AD2F-502F057C3ED5Q26999712-EB8176EE-2AC7-4318-9A7B-A0F737EDBDF1Q27014726-A84F1A20-7F97-42E2-A55C-2EEA26478F9BQ27680833-46D7D200-C919-4FF3-AA3F-6EE7530ABBDDQ27928046-0D03C532-3C82-485A-BDD4-817BE3227136Q28068209-59FF44F6-7523-41F9-9962-0039CACDB5C6Q28077066-98C49CBC-7FE4-4BAF-9B6C-EBC0DEDBF911Q30486743-AD136162-D9E6-47A2-A9A6-B572763D1045Q33705688-D3969A8F-1828-4589-82F3-B08BF3FBD44CQ33828993-B133964D-D09E-437F-962B-42C2C7D58CA2Q34253116-88824A42-2F62-41FA-82B0-6AED8CF0298AQ34382931-05579EF0-8C29-49BC-BFC6-AD8580FAC1AAQ34425909-A3E5145F-ED7C-484E-AC12-CD5014778376Q34554302-5780E1CB-B9E6-4905-9887-8FCDEAC69364Q35247159-3D682012-4442-4571-8539-56ED6B6FDF03Q35559131-6590A38B-8E62-4377-B1F5-E6C058676931Q35800368-B23749BD-8615-493E-8B08-1D62CC401A76Q36167561-26CDCACF-F2D6-4BB9-A93C-EBF535CC3B3BQ37076495-92117FA4-14E8-4D35-A261-7CA93F5A8488Q37399967-4FD5389D-C9C7-4F26-B980-513AA609623BQ37575666-2A1C5BEB-E1B9-4182-A330-C80DBF74DA17Q37601598-0E47F274-24A9-4169-A0B0-F71EE05D5358Q37689641-C9D1B8C8-7136-4B03-91C8-652594C3C729Q38588958-5CDBD043-4A52-4F10-BDB2-49DB2EA4FB0CQ38619018-2D05E941-633B-4E7B-802C-24C63D1373D0Q38775846-47BB450E-E040-437A-B20E-8BBC2549CB8EQ40065913-58CAA643-F5BA-43C8-9A91-F2E66087577FQ41143699-42E29AE3-26CB-4337-A14E-F209F8C8B035Q41631979-C7358390-14C4-43D0-BA79-96793C307ED0Q42314725-6A66E87F-54DB-45FD-9D0C-E95057F4D96DQ46249217-6DF02CC7-2589-4567-B10E-969F81AC3122Q47873443-A3082CA2-9F05-4004-AE6D-CE28CF4FDCCBQ51736544-0A6A3324-1CAE-4B8F-8C21-6B0D01381C13Q54985457-5AD53CC4-2400-44DA-B6FA-CB3552B170C7Q57492155-88955A2C-AD01-4562-ACFA-1E4A196246AAQ58114687-101D92FD-EE69-4956-944B-000C8B7D3241
P2860
The solute carrier family 10 (SLC10): beyond bile acid transport
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The solute carrier family 10 (SLC10): beyond bile acid transport
@ast
The solute carrier family 10 (SLC10): beyond bile acid transport
@en
type
label
The solute carrier family 10 (SLC10): beyond bile acid transport
@ast
The solute carrier family 10 (SLC10): beyond bile acid transport
@en
prefLabel
The solute carrier family 10 (SLC10): beyond bile acid transport
@ast
The solute carrier family 10 (SLC10): beyond bile acid transport
@en
P2093
P2860
P1476
The solute carrier family 10 (SLC10): beyond bile acid transport
@en
P2093
James E Polli
Peter W Swaan
Tatiana Claro da Silva
P2860
P304
P356
10.1016/J.MAM.2012.07.004
P577
2013-04-01T00:00:00Z